Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $825.72 | 13 | 99.1% |
| Education | $7.29 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $288.33 | 4 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $168.82 | 2 | $0 (2020) |
| Novo Nordisk Inc | $105.85 | 1 | $0 (2018) |
| Gilead Sciences, Inc. | $79.63 | 1 | $0 (2019) |
| Amgen Inc. | $78.80 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $41.35 | 2 | $0 (2019) |
| COLOPLAST CORP | $36.92 | 1 | $0 (2021) |
| Amarin Pharma Inc. | $19.58 | 1 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $13.73 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $36.92 | 1 | COLOPLAST CORP ($36.92) |
| 2020 | $139.45 | 2 | Janssen Pharmaceuticals, Inc ($119.87) |
| 2019 | $527.78 | 9 | AbbVie, Inc. ($288.33) |
| 2018 | $128.86 | 2 | Novo Nordisk Inc ($105.85) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2021 | COLOPLAST CORP | Restorelle (Device) | Food and Beverage | In-kind items and services | $36.92 | General |
| Category: Women's Health | ||||||
| 11/13/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Cardiovascular | ||||||
| 02/26/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $119.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2019 | AbbVie, Inc. | Rinvoq (Biological) | Food and Beverage | In-kind items and services | $90.23 | General |
| Category: Immunology | ||||||
| 11/14/2019 | AbbVie, Inc. | Rinvoq (Biological) | Education | In-kind items and services | $7.29 | General |
| Category: Immunology | ||||||
| 10/17/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $78.80 | General |
| Category: Neuroscience | ||||||
| 08/22/2019 | Gilead Sciences, Inc. | Truvada (Drug) | Food and Beverage | In-kind items and services | $79.63 | General |
| Category: HIV | ||||||
| 07/31/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: WOMENS HEALTH | ||||||
| 04/17/2019 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug), Mirena | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Women's Health | ||||||
| 04/03/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $104.97 | General |
| 02/27/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $85.84 | General |
| Category: Immunology | ||||||
| 02/06/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $48.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $105.85 | General |
| Category: Diabetes | ||||||
| 09/05/2018 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 750 | 873 | $116,223 | $39,108 |
| 2022 | 25 | 768 | 903 | $115,037 | $38,740 |
| 2021 | 5 | 108 | 124 | $22,127 | $7,635 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 168 | $51,858 | $13,755 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 59 | 59 | $18,556 | $7,492 | 40.4% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 26 | 26 | $9,289 | $3,340 | 36.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 40 | 40 | $6,170 | $2,877 | 46.6% |
| 77067 | Screening mammography | Office | 2023 | 19 | 19 | $7,562 | $2,533 | 33.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $2,467 | $1,224 | 49.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 100 | 135 | $1,873 | $1,067 | 57.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 21 | $4,573 | $1,057 | 23.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 59 | 65 | $2,438 | $1,056 | 43.3% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 26 | 26 | $1,040 | $1,043 | 100.3% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 19 | 19 | $2,964 | $1,032 | 34.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 50 | 51 | $1,658 | $669.12 | 40.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 26 | 41 | $2,702 | $626.95 | 23.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 29 | 43 | $935.25 | $399.84 | 42.8% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 57 | 59 | $855.50 | $363.46 | 42.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 34 | 35 | $778.75 | $355.28 | 45.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 11 | 15 | $270.00 | $109.39 | 40.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 11 | 12 | $237.00 | $106.08 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 172 | $51,892 | $14,473 | 27.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 55 | 55 | $16,995 | $7,164 | 42.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $8,208 | $3,345 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 32 | $6,840 | $1,686 | 24.6% |
| 77067 | Screening mammography | Office | 2022 | 11 | 11 | $4,252 | $1,444 | 34.0% |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | Office | 2022 | 11 | 14 | $2,380 | $1,035 | 43.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 31 | 56 | $3,584 | $989.76 | 27.6% |
About Dr. Sharda Tajane, MD
Dr. Sharda Tajane, MD is a Family Medicine healthcare provider based in Marysville, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2018. The National Provider Identifier (NPI) number assigned to this provider is 1255823373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sharda Tajane, MD has received a total of $833.01 in payments from pharmaceutical and medical device companies, with $36.92 received in 2021. These payments were reported across 14 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($825.72).
As a Medicare-enrolled provider, Tajane has provided services to 1,626 Medicare beneficiaries, totaling 1,900 services with total Medicare billing of $85,484. Data is available for 3 years (2021–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Marysville, WA
- Active Since 06/04/2018
- Last Updated 02/16/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1255823373
Products in Payments
- XARELTO (Drug) $168.82
- Victoza (Drug) $105.85
- Rinvoq (Biological) $97.52
- Humira (Biological) $85.84
- Truvada (Drug) $79.63
- Aimovig (Biological) $78.80
- NEXPLANON (Drug) $41.35
- Restorelle (Device) $36.92
- Vascepa (Drug) $19.58
- Kyleena (Drug) $13.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Marysville
Dr. John Colombo, Md, MD
Family Medicine — Payments: $14,480
Dr. Delia Herzog, M.d, M.D
Family Medicine — Payments: $8,380
Dr. Daniel Badenhop, M.d, M.D
Family Medicine — Payments: $8,359
Dr. Jeffrey Moore, M.d, M.D
Family Medicine — Payments: $5,818
Dr. Wendy Summerhill, M.d, M.D
Family Medicine — Payments: $4,265
Igor Nedic, M.d, M.D
Family Medicine — Payments: $2,191